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Abstract
Ethics in medical sciences research may not always translate into ethical publications.
Unfortunately  due  to  lack  of  regulatory  bodies,  publication  misconduct  is  now a
global  menace  for  the  scientific  community.  Publication  misconducts  are  not  only
restricted to research fraud or data manipulations alone but also seriously include
plagiarism,  duplicate  publications  especially  on  figures  and  tables,  authorship
disputes and conflict of interests. As global scientific research is expanding particular‐
ly in the field of health sciences hence possibilities of more rise of unethical practices
from research to publications are very high, authors suggest a strong peer‐reviewing
system,  use  latest  technological  support,  strong  publication  ethics  policies,  active
monitoring,  protection of whistle blowers and more liaisons between journals and
research  institutions  or  universities  possibly  to  prevent  publication  misconduct
effectively.  This  chapter  discusses  how  medical  publications  might  have  abused
various ethical norms not only while conducting research but also during the publica‐
tion  process.  The  review  also  discusses  the  possible  preventive  measures  against
unethical practices of research publications.
Keywords: scientific misconduct, medical journals, ethical publications
1. Introduction
Ethics in medical sciences research may not always translate into ethical publications. As peer
pressure rises the ethics of conducting medical research and subsequent writing scientific
papers and publications gradually erodes in the last couple of years. This phenomenon so
much  deeply  penetrates  into  the  medical  researchers  that  various  professional  bodies,
universities and governments are forced to press panic button against unethical  medical
research  and  publications  [1].  Ethical  violations  in  conducting  medical  research  always
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promote unethical scientific publications. The most important outcome of any research is its
findings and observations and definitely improper research or scientific misconduct will lead
to  unethical  publications.  The  research  misconduct  that  promotes  unethical  publication
impacts  badly  on  other  researchers  who  follow  the  steps  shown  in  unethical  scientific
publications and resulting wrong practices or applications on patients [2].  Scientific and
research misconduct is defined very clearly by the Royal College of Physicians at Edinburgh
—‘as any behaviour by a researcher, whether intentional or not, that fails to scrupulously
respect high scientific and ethical standards. Various types of research misconduct include
fabrication or falsification of  data,  plagiarism, problematic  data presentation or analysis,
failure to obtain ethical approval by the Research Ethics Committee or to obtain the subject's
informed consent, inappropriate claims of authorship, duplicate publication and undisclosed
conflict of interest (COI)’ [1]. The statement specifically mentioned that research misconduct
does not end at the research works level but also extends to the publication level. One must
note  that  research  misconduct  either  is  done  intentionally  or  unintentionally—hardly  it
matters on its impact to the society that includes fellow researchers, authors, reviewers, editors,
institutes, universities, nations and above all future students of medicine, professionals and
patients as a whole. In the era of ‘publish or perish’ medical fraternity should not focus only
on his/her career advancement but also consider the professional ethics including research
and publication ethics seriously [3]. How serious a research misconduct may be the story of
South Korean stem cell scientist Woo Suk Hwang is enough to speak to that! Dr. Hwang's
revolutionary work on stem cells published in Science (2004 and 2005) and later found that
both the papers are fakes [4].
According to Fanelli, research misconduct should be redefined as ‘any omission or misrepre‐
sentation of the information necessary and sufficient to evaluate the validity and significance
of research, at the level appropriate to the context in which the research is communicated’ [5].
Faneli also stated that ‘scientific knowledge is reliable not because scientists are more clever,
objective or honest than other people, but because their claims are exposed to criticism and
replication’ [5].
The consequence of research misconduct not only tarnishes the image of the spirit of science
but also collaterally damages many things like:
1. Society and humanity: Wrong procedures, false and fabricated data bring out products,
which may be considered unsafe for humanity. Here comes the publication ethics
regulation, which perhaps control or prevent these danger.
2. Fellow researchers: Published data and knowledge derived from research misconduct in
medical sciences will mislead fellow medical researchers and that will lead to huge loss
of money, funds, times and reputations.
3. Medical practitioners and students: Medical practitioner also suffers a lot due to unethical
research publications as many wrong diagnostic and therapeutic published guidelines
lead to professional disaster for them. Medical students might be taught subjects and
understanding based on false and fabricated data which will jeopardize the career of
future doctors.
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4. Public trust and Government policies: Research misconduct and subsequent unethical
publications may destroy public trust on science. Such false information and data may
misguide government and lead to implement some erroneous health policies and laws.
The ultimate sufferers are common man and society.
Hence, we can say that all the stakeholders from researchers, institutions/universities,
government agencies, medical journals or book publishers are going to be devastated by
research misconduct, which may also be considered as the most serious scientific assault on
human health sciences.
While conducting medical research, researchers are usually careful and take all the precautions
against any sort of ethical violation either in human or in animal research as per the guidelines
of various apex professional bodies. Institutional Regulatory Body/Institutional Ethical
Committee of all the countries function near similar pattern which strictly follow Declaration
of Helsinki and other international guidelines. In general, all the institutional ethics committee
critically obey all the ethical principles as per the Declaration of Helsinki by World Medical
Association (WMA), National Institute of Health (NIH), the Food and Drug Administration
(FDA), Environmental Protection Agency (EPA), Singapore statement of research integrity,
ICMR guidelines, etc. In a nutshell, American Psychological Association comes out with five
principles for research ethics: (i) discuss intellectual property frankly, (ii) be conscious of
multiple roles, (iii) follow informed consent rules, (iv) respect confidentiality and privacy and
(v) tap into ethics resources [6]. NIH also summarizes the principles of ‘Codes and Policies for
Research ethics’ as the following: (i) honesty, (ii) objectivity, (iii) integrity, (iv) carefulness, (v)
openness, (vi) respect for intellectual property, (vii) confidentiality, (viii) responsible publica‐
tion, (ix) responsible mentoring, (x) respect for colleagues, (xi) social responsibility, (xii)
nondiscrimination, (xiii) competence, (xiv) legality, (xv) animal care and (xvi) human subject
protection [7]. Unfortunately, such strong and mandatory authority is unavailable in case of
research publications.
1.1. Aims
This review is undertaken to discuss how medical publications might have abused various
ethical norms not only while conducting research but also during the publication process. The
review also discusses the possible preventive measures against unethical practices of research
and publications.
1.2. Manifestations of medical research misconduct
There are several ways in which ethical violation in medical research are noticed, namely
altering instrumentation or research procedure, nonreplicable findings, copying ideas,
copying results, false study design, inadequate data, falsifying ethical consent, image manip‐
ulations, plagiarism, duplicate publication, etc. These unethical practices are taken place at
each of the steps in research, that is performing works to disseminating knowledge through
scientific publications [8, 9]. The most common research misconduct, which is manifested
through publications, is falsifications and fabrication of data. As per NIH, ‘fabrication’ means
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‘the intentional act of making up data or results and recording or reporting them’ whereas
‘falsification’ is manipulating research materials, equipment or processes, or changing or
omitting/suppressing data or results without scientific or statistical justification, such that the
research is not accurately represented in the research record [10]. It is noticed that ‘figures’ and
‘graphics’ where maximum fabrications or falsification take place. The graphical manipula‐
tions are mainly through Photoshop and journal editors are struggling hard to fight against
these hi‐tech manipulations on research data [11, 12]. Overall, we can say that research
misconduct manifestation is multidimensional. These may be classified as (1) General research
misconduct, (2) Research application misconduct, (3) Data generation misconduct, (4) Finan‐
cial misconduct, (5) Behavioural misconduct and (6) Publication misconduct.
The foremost important manifestation is general research misconduct, which includes fabrication,
falsification and plagiarism. These three unethical research practices are very serious offences
as it makes research either misrepresented by the facts or underrepresented by the truth.
Usually, such unethical practices in research are due to peer pressure and personal gains and
pressure from research sponsors. Research application misconduct usually occurs while adopting
wrong or poor research design or technical errors during experimental, computational and
statistical analysis. Improper uses of human subjects, patients or animals also lead to research
misconduct and result in ethical violations. Data generation misconduct includes false data
generation, not including real data in research, not sharing true data with colleagues’ especially
multicentre studies. Financial misconduct in research usually includes misuse of research funds
like unauthorized purchase procedures, use of research funds for personal reasons, disclosure
of conflict of interest, etc. Behavioural misconduct covers inappropriate behaviours towards
colleagues, research scholars and gender and religious insensitivities on students, colleagues,
patients and subjects. Usually, publication misconduct occurs due to authorship dispute, ghost
and gifted authorship, plagiarism, duplicate publication and suspicious clinical trials. Study
on misconduct in clinical trials found that the most serious forms of research misconduct in
clinical trials are selective and biased reporting [12, 13].
1.3. Factors that influence research misconduct
Various factors actually induce research misconduct like:
1. Publish or Perish pressure.
2. Severe competition for funds.
3. Promotion or career advancement policies.
4. Pressure from research sponsors to obtain desired results.
5. Lack of knowledge on research ethics.
6. Desire to ‘go ahead’.
7. Personal characters.
In most of the cases, research misconduct is suspected, identified and reported by colleagues.
Usually, researchers who work alone and never allow others to observe his or her research
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works or researchers who are self centric and do not have an attitude to work in a team are
primarily prone to do research misconducts. Research findings in medical sciences should be
always repetitive at any place and anytime. Failure to repeat research results by one's own
laboratory or external laboratories definitely suspect misconduct.
1.4. Questionable research practices in medicine
These are some criteria which are not direct research misconduct but definitely raise suspicion:
1. Failing to retain significant research data for a reasonable period.
2. Maintaining inadequate research records, especially for results that are published or are
relied on by others.
3. Conferring or requesting authorship on the basis of a specialized service or contribution
that is not significantly related to the research reported in the paper.
4. Refusing to give peers reasonable access to unique research materials or data that could
support published papers.
5. Using inappropriate statistical or other methods of measurement to enhance the signifi‐
cance of research findings.
6. Inadequately supervising research subordinates or exploiting them.
7. Misrepresenting speculations as fact or releasing preliminary research results, especially
in the public media, without providing sufficient data to allow peers to judge the validity
of the results or to reproduce the experiments.
1.5. Reasons for questionable research practices
The reasons for questionable research practices may be due to poor supervision, excessive
workloads, poor training in research, lack of interest of researchers and being over ambitious.
These can be found in principal investigators, study coordinators, research scholars, admin‐
istrative staff, technicians and even the research subjects themselves.
1.6. How questionable research misconduct is done?
The following are some examples of questionable research misconduct [14]:
– Dates misrepresented.
– Duplicate X‐rays: different names.
– Blank laboratory reports to fill in.
– Fake subjects: obituary names.
– Analysis done after subjects died.
– Same subject different names.
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– Nonexistent subjects created.
– Dates changed in records to match washout periods.
– Consent not signed before entering the study.
– Unqualified staff doing research.
– Inadequate records.
– Failure to get IEC/IRB approval.
– Failure to report changes in research.
– Bogus laboratory results reported.
– Samples study from only a few subjects.
– Subjects received prohibited medication while on study.
– Failure to report adverse events.
Hence, we can say that from knowledge generation (ethical research) to knowledge dissemi‐
nation (ethical practices and publications) – medical ethics is a common component of research
integrity and medical science research cannot afford to lose this integrity for the interest of the
humanity (Figure 1).
Figure 1. Research integrity through ethical research, practice and publication.
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2. Publication ethics
Graf et al. [15] said that academic publishing depends mainly on ‘trust’. In the system of
research publication procedure, editor trusts reviewers, authors trust editors by expecting fair
reviewing processes and finally readers trust authors, reviewers and editors for providing
honest sciences. In general, common public outside of research community considers physi‐
cians and scientists are just demigod with high morale and integrity. ‘Scientists are generally
perceived as well‐intentioned seekers of truth; universities, as cathedrals of learning and as
producers of knowledge vital to the health and welfare of society’ [16]. Unfortunately, reports
of unethical research publications shake the public confidence on medical scientists. Although
medical practitioners, teachers and researchers can recognize publication misconduct and
ignore that to some extent, chances of un detection of mistakes and doubtful observations are
also may lead to serious consequences. Thorough understanding of publication ethics in
medical research is need of the hour. World Association of Medical Editors (WAME), Interna‐
tional Committee of Medical Journal Editors (ICMJE) and Committee on Publication Ethics
(COPE) are the guiding force to interpret ethical publication appropriately [14]. They have
provided guidelines on the publication ethics policies for medical journals on various issues
such as study design, authorship, peer review, editorial decisions and plagiarism and also
further guided the procedural guidelines to tackle those publication misconduct. These bodies
also enlighten editors on various issues such as conflict of interest, authorship disputes,
redundant publications, fabrication of data, plagiarism and human and animal rights [17].
2.1. Ethical issues
2.1.1. Why do publication ethics matter?
Published research influences other researchers and establishes credibility for individual or
journal. Honest scientific reports build trust among peers and within scientific community.
Publication ethics is not confined to one country—it is global by approach and is commonly
held throughout the world. Author's seven deadly sin: Table 1 depicts unethical practices of
authors.
2.1.2. Plagiarism
In the era of copy and paste, an excessive dependence on search engine make plagiarism a
universally popular among the medical scientists who like to prefer a short cut for the way of
success in publication. Plagiarism is defined as ‘to copy ideas and passages of text from
someone else's work and use them as if they were one's own’ [18]. The word plagiarism may
be further extended to unreferenced use of the ideas of others submitted as a ‘new’ paper by
a different author! One must know plagiarism may not be considered always as accidental.
The most vulnerable part for plagiarism in any research publication is ‘methods’.
Another form of plagiarism is self‐plagiarism where author copy and paste from his/her
previous publications including results, tables and figures without providing copyright
clearance certificate from publishers. Self‐plagiarism is also an equal crime or research
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misconduct like simple plagiarism. Fortunately, due to the availability of many anti‐plagiarism
softwares, this menace has cut down notably. Editor must make his/her peer reviewers alert
and possibly train them on this issue. Universities, medical institutes and funding authorities
should also sensitize its medical researchers and practitioners on it. The best way to avoid
plagiarism is to cite other's work always in the research articles, put the cited words in
quotation marks and seek permission from appropriate authorities for references to cite tables,
figures, etc. COPE has given a very useful guideline through flow chart on plagiarism for both
submitted manuscripts and published manuscripts [18]. The Committee on Publication Ethics
(COPE) is a UK‐based charitable organization (established 1997) working mainly on research
and publication misconduct. COPE has provided some very authentic guidelines addressing
publication ethics from authors, reviewers, editors and publishers’ point of views. COPE
defines the good practices in publication of research articles, which are really very helpful for
authors, readers, editors, peer reviewers, editorial board members and journal and book
publishers. COPE is the first organization, which advocates accountability of research institu‐
tions for its employee scientist's misdeed [19]. ICMJE also directs authors and editors to follow
COPE guidelines in case of suspected unethical practices on publications or any ethical
dispute [20].
Sl. no. Sin Example
1 Carelessness Citation bias, understatement, negligence
2 Redundant publication Same tables or literature review reported without noting prior source
3 Undeclared conflict of
interest 
Failure to cite funding source
4 Unfair authorship Failure to include eligible authors, honorary authors
5 Human/animal subjects
violations
No approval from review board or ethics committee
6 Plagiarism Reproducing others’ work or ideas without as one’s own
7 Other fraudulences Fabrication or falsification of data, misappropriation of other ideas or plans
given in confidence
Table 1. Author's ethical misconduct.
2.1.3. Redundant publications
Redundant or duplicate publication is another serious issue pertaining to ethical publications.
It is often revealed by reviewers and readers. In the modern era of Internet, it is relatively easy
to find out such unethical publication in the form of duplicate publication. Many times, it
happens without the knowledge of co‐authors or the group of researchers who published it in
previous journal. This unethical publication actually causes serious damage on humanity [21].
It makes waste of time of peer reviewers and editors, waste journal print pages unnecessarily.
Redundant publication sometimes assault on academic reward system. It also violates
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copyright acts and inflated number of publications that injure society as a whole. Below, the
facts that make redundant or duplicate publications are mentioned:
• Data in conference abstract? – No
• Same data, different journal? – Yes
• Data on website? – May be
• Data included in review article? – No if permission is taken
• Expansion of published data set? – Yes
There are certain norms that may help clarify further on duplicate publications like if one takes
an approval from both the journals and subsequently publishes, it may not be considered as
‘duplicate’. Secondary version for paper intended to different language readers with appro‐
priate permission may not be taken as ‘duplicate’. But in any case secondary version faithfully
reflects data and interpretations of the primary version with a clear message that it is the
secondary publication for journal ‘y’ based on previously published article (primary) in journal
‘x’ in ‘z’ language. COPE has given some useful guidelines on how to handle suspected
redundant (duplicate) publications, especially for journal editors. COPE instructed that at the
beginning editor must verify whether it is the case of major or minor redundancy. Major
redundancy is always considered with evidence of deliberate duplication such as changes of
title and data sheet with identical findings. Minor redundancy is something ‘salami publica‐
tion’ types with looks of extended follow‐up of previously published article. Whatever it may
be, editor must contact corresponding author and ask explanation, if satisfied, do not take any
action. If it is not found satisfactory, editor has many choices such as inform the incidence to
author's superior organizational authority/employer or prompt rejection of manuscript or
notice of retraction immediately [22].
2.1.4. Authorship disputes and ethical misconducts
Probably, one of the most discussed and complex ethical violation in publication in medicine
is authorship disputes and ethical misconducts. The difference between ‘disputes’ and
‘misconduct’ may be proclaimed as follows:
Disputes—‘Question of interpretation’ like whether ‘contribution’ by the authors was substan‐
tial? Whether authorship criteria were discussed when research was planned ? Or it was
decided before submission of manuscript?
Misconduct—Authorship is unethical like ‘gift’ or ‘ghost’ authorship.
Regarding authorship issue, International Committee of Medical Journal Editors (ICMJE)
guidelines states ‘anyone who has made a substantial contribution to the conception, design
or acquisition of data or analysis and interpretation of data, drafting or revising the article for
intellectual contents, or participated in the final approval of the version to be published is
entitled to be an author’ [23]. The studies revealed that ‘gift authorship’ is prevalent among
authorship misconducts. Gift authorship is usually taken place when research or administra‐
tive hierarchy comes in to the picture or because of a colleague with whom we have a personal
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relationship like son/daughter or husband/wife/relatives etc [24]. But senior researchers or
administrative boss who have substantial contribution on the subject at any point like writing
manuscript, editing manuscript, reviewing manuscript and providing additional knowledge
with high intellectual input on writing science are not considered as ‘gifted’. One must clearly
remember that simply helping research by way of logistic supports such as sample collections,
patients supply, chemicals and reagents supply, helping data collections or providing research
funds are not the criteria to become an author [1, 25]. Another unethical authorship dispute is
‘ghost authorship’. Ghost authors are the researchers who writes the research article without
acknowledgement. This is very common for many cases where researcher drafts an article at
the behest of pharmaceutical company. Here, the real author's name never comes in domain
of publication. The problem of the ghost author is that whatever they write may not always
be correct interpretation and may be biased; hence, it badly affects the researcher community.
COPE, ICMJE and WAME have given certain guidelines to tackle this publication misconduct
issue. Following are the summarized form of guidelines:
• Journals must have clear authorship criteria.
• Authors should disclose all contributors, regardless of author status and their specific
individual contributions and affiliations.
• Authors must sign about their contributions details.
• Authors should disclose any of his/her conflict of interest and a statement whether they have
received any support from medical writers [26].
Hence to be précise, it may be stated that as per ICMJE guidelines, the three important
mechanics of authorship are ‘intellectual input in research, contribution in writing and final
written approval of the manuscript’ [23, 27]. ICMJE also specifies that authorship criteria
should be based only on:
• Substantial contributions to conception and design, or acquisition of data, or analysis and
interpretation of data.
• Drafting the article or revising it critically for important intellectual content.
Examples of publication misconduct are authorship disputes and misconducts, which are very
common in the medical professionals. Various studies in this regard showed the nature and
execution of such unethical practices among medical professional. Works of Dhingra and
Mishra [3] revealed that majority of respondent on questionnaires confirm publication
misconduct especially authorship disputes among Indian biomedical researchers. Another
study of Das et al. [25] observed clear authorship misconduct among medical faculty members
of India. In their study, they have found that around 81.4% respondents from medical faculty
members confessed authorship disputes in any form among themselves. Further, a compara‐
tive study with pharmacy faculty members the dispute level was found to be 29.2%, which
further indicates that medical researchers are more vulnerable to authorship misconduct. The
study also showed that 74.07% of medical and 68.29% of pharmacy faculty members did not
have any discussion on authorship issues at any time before they actually started drafting
article for publication. About 88.88% of medical and 36.5% of pharmacy faculty members also
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mentioned that their professors and head of the departments were included as author although
they do not have any contributions or they do not fit in ICMJE authorship criteria. About 81.4%
of medical and 29.26% of pharmacy faculty members also mentioned in questionnaires that
senior research colleagues interfered while writing manuscript to include their names in the
drafted manuscripts. Das et al. further elaborated that even though pharmacy faculty members
are better practioners of ethical authorship as compared to their medical counterparts still more
sensitization is needed for them to realize ethical authorship [25]. To regulate authorship
disputes and misconduct the role of corresponding author should be considered the most
important one although other co‐authors are also accountable. Every author must have
substantial research contribution to justify their inclusion as author. All authors must take their
responsibility on manuscript's every pros and cons. The accuracy of all the data, conflict of
interest, disclosure of funding authority and get manuscript checked by all the co‐authors are
the responsibilities must be put on corresponding or principal author's shoulder [9].
2.1.5. Conflict of interest
One of the important but less admitted examples of publication misconduct is nondisclosure
of conflict of interest. It may be financial (industry sponsor research) or others like personal
interest like employment interest, promotion or career advancement interest, patents, personal
believes, grant providing, relationship, academic competition or intellectual passion, etc [23,
28]. Most of the journals make disclosure of potential conflict of interest mandatory and do not
publish articles even after acceptance if COI is not disclosed. It has been reported in a study
on five leading medical journals like Annals of Internal Medicine, BMJ, Lancet, JAMA, New
England Journal of Medicine that only 52 of total 3642 articles disclosed their potential COI, that
is only 1.4% of total [29]. Another study also showed that one in three lead authors had financial
interests in their research by patents, shares or payments for being on advisory boards or as a
director, etc [30]. A study conducted by Das et al. [31] on awareness of COI among medical
scientists/researchers from India showed that only 12% authors understand COI issues
correctly and 19 % of medical authors just heard about it. Very interestingly, the authors who
had clear knowledge on COI confessed that hardly they provide COI statement to the journal.
The study also found that knowledge of COI is equally poor even among peer reviewers (30%)
and editorial board members (25%) too! Some peer reviewers even stated that they are biased
toward articles submitted by their known colleagues from medical sciences [31]. Another study
also showed that there are no clear guidelines for institution and industries are other cause of
COI‐related issues [32]. In the complex scenario of COI issues among medical publications,
editor of the journals, peer reviewers, research institutions or universities and grant providers
must pay more attention to tackle this unethical issue in publications [32]. Das suggested COI
case comes out even after publication, in which, the publisher and editor may apologize and
issue a formal correction and subsequently retract the article [33].
2.1.6. Fabrication and falsification of data
Fabrication means cooking up data or results (fictitious by nature) as per the hypothesis of
research and publishes it in a journal whereas falsification is simply manipulating data or
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results. It also includes figures or graph distortions. Fabrication also covers selective reporting
where authors just report a small number of significant values of the study but hide large
number of insignificant observations. Such biasness completely destroys the spirit of science.
Normally, both fabrication and falsification of research observations are common for clinical
trials (pressure from sponsors) and research activities of medical researchers who have a
tendency to go alone instead of working as a research team [1]. In an interest meta‐analysis
study, Fanelli [9] reported that around 2% of studied medical scientists confessed that they had
fabricated or falsified research data. Nearly, one‐third of the said study group also confessed
that they allowed many publication malpractices including ‘dropping data’ results of a study
in response to pressures from a funding source [9]. The issues on fabrication and falsification
of data are very serious by nature, and unfortunately, even the world's top medical research
institute faculties are also involved in it. Story of John Long, a pathologist at Harvard Medical
School was compelled to resign after publication of his false and fake results on molecular
immune complexes related to Hodgkin's disease [34]. Similarly, one Dr. Vijay Soman of Yale
University was found an offender on publication ethics because of fabrication and falsification
of data from his colleague [35]. This problem is not only restricted on medical researcher/
author, but it is even extended to editor also. Malcolm Pearce who was an Assistant Editor of
British Journal of Obstetrics and Gynaecology was found to be a publication ethics defaulter. His
false case report based on a patient who had gone under successful delivery after reimplanting
an ectopic pregnancy was actually nonexisting. Later, his all papers were retracted from
various journals [36]. One of the classic example of data fabrication is the story of Ram B. Singh
between India. Dr. Singh submitted nine papers from 1992 to 1996 on his research on diet and
myocardial infarction. The then Editor of BMJ Professor Richard Smith suspected on Dr.
Singh's work and asked him to produce raw data. Dr. R. B. Singh failed to produce that and
insisted that data were ‘eaten by termites’. It was also found that the institution where he did
his research was owned by his family members. BMJ initiated an independent inquiry and
published his story [37].
3. Publication ethics
3.1. Best practices
Based on ICMJE and COPE guidelines for publishers, editors, peer reviewers and authors must
practice and train themselves against publication misconduct. One of the most important
things to promote ethical publication is to encourage research integrity among medical
researchers. COPE advocated for a research integrity officer in each of the research institution
to monitor and guide various issues pertaining to research ethics including publication ethics
[18]. Research Institutions share a responsibility with all of its researchers to preserve scientific
integrity in research. They bear the primary responsibility for promoting a culture of good
scientific conduct among researchers and students and for the prevention, investigation and
punishment of scientific misconduct in their midst. One must remember that research integrity
requires the highest professional standards by a critical, open‐minded approach, frankness
and fairness with absolute honesty.
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3.1.1. Publishers, editors and peer reviewers
An editor must take into consideration some important points before sending manuscript for
reviewing like whether competing interests are cited by authors or reviewers, ensures that
reviewer is adequately qualified and can keep confidentiality and also protects the whistle
blower in case of reports on publication misconduct. It is suggested that journal editors must
provide a link to WAME or COPE or ICMJE for authors, readers or reviewers to get first‐hand
information on ethics in publication. Editors should encourage peer reviewers to consider
ethical issues on research manuscripts while reviewing and may also ask additional informa‐
tion from authors if need arises. Journals editors and publishers must protect confidentiality
of research that includes identity of subjects/patients, etc besides identity of reviewers. Editors
may also verify institutional review board clearance on each of the research manuscript in
medical journal [15]. Ethical publication also includes timely peer reviewing and publication
of the manuscript which is the responsibility of editor and publisher. Authors’ especially
medical authors always should be sensitized by editors, publishers and institutions that
medicine is a profession based on ‘absolute trust, philanthropy and altruism’. For ethical
publication, the great role of peer reviewers must also to be remembered. Reviewer should be
competent enough to review the content of manuscript; he/she should not be in hurry, no COI
issues, have knowledge on publication ethics. One more important point on best practice for
editors is to remain cultural and gender sensitive on any article. They should carefully observe
whether any cultural offence is in the content of manuscripts. Language of the authors should
not offend anyone among the readers [15].
3.1.2. Prevention
To regulate appropriately on the issues of ethical publications, institutions or universities
should be accountable by the journal publishers for any unethical publication practices
authored by the researchers belong to that institution. COPE or ICMJE have given some
guidelines but that do not make institutions of author as accountable for any publication
misconduct. Institution must have clear and transparent functioning on not only ethical
research policy but also on ethical publications. Institution of authors and journal must take a
special attention on the clinical trial‐based publications. A Strong peer‐reviewing system, uses
of latest technological support, strong publication ethics policies, active monitoring, protection
of whistle blowers and more liaisons between journals and research institutions or universities
possibly prevent publication misconduct effectively.
In a summary, we may say that the following points may be considered to prevent publication
misconduct:
• Better education on publication guidelines and ethics.
• Introduction of registers for planned and ongoing clinical trials.
• Change criteria from quantity to quality when papers are used for assessment of posts or
grants.
• Punish the culprits but be careful that innocent is not victimized.
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